GMJ Briefs
What You Need to Know About the NHS Prostate Cancer Screening Expansion
NHS prostate cancer screening now starts at age 50 for black men and combines PSA tests with MRI for superior…
What the England Syphilis Data Means for STI Prevention Strategy and Health Equity
England's syphilis prevention success offers lessons in targeted interventions—and warnings about addressing emerging disparities in STI prevention.
What MHRA’s 47 New Medicine Approvals Mean for UK Healthcare Stakeholders
MHRA's 47 approvals signal robust pharmaceutical innovation access, but NICE health economic evaluation will determine NHS funding and clinical implementation.
NHS England Brings Precision Radiotherapy to Prostate Cancer Patients Nationwide
NHS England expands precision radiotherapy access for prostate cancer, reducing treatment sessions from 20 to 5 while improving patient outcomes.
Key Finding: Pennsylvania Schools Distribute Debunked Vaccine Misinformation to Thousands of Parents
Thousands of Pennsylvania parents received debunked vaccine materials from their school districts, despite extensive research involving millions of children consistently…
Takeaway: New Pancreatic Cancer Drug Daraxonrasib Shows Promise in Phase 2 Trial
Key takeaways from new pancreatic cancer study: 1) Novel targeted therapy tested in phase 2 trial 2) Compared to standard…
What England’s Rising Herpes Cases Mean for Your Sexual Health
Rising herpes cases in England underscore importance of regular STI testing, particularly for young adults at highest infection risk.
What UK Patients Need to Know About Parallel Import Medicine Access
UK parallel import licences ensure patients access quality medicines from EU sources while maintaining full regulatory oversight and safety standards.